-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
SARS-CoV-IN-2
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/888958-26-7.gif)
| Category | SARS-CoV |
| CAS | 888958-26-7 |
| Description | SARS-CoV-IN-2 is one of hydroxyferroquine derivatives with antimalarial and antiviral activities, and also an effective inhibitor of SARS-CoV replication. |
Product Information
| Molecular Weight | 455.72 |
| Molecular Formula | C24H18ClFeN3O |
| Purity | 98% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Light yellow to yellow (Solid) |
| Storage | Store at -20°C |
| Target | SARS-CoV; Parasite; HIV |
